FDA greenlights new COVID-19 shots for this fall - Roll Call The FDA approved reformulated COVID-19 vaccines from Pfizer and Moderna, but deferred an expected authorization for Novavax’s vaccine. Roll Call · Sep 11, 2023
Poor countries face vaccine inequity Vaccination is a global strategy, yet many low-income countries can't access then, perpetuating the pandemic Salon · Sep 10, 2023
This Biotech Stock Offers Innovative Growth at a Massive Discount Moderna stock continues to sag, even as new COVID variants emerge. However, investors may be underestimating the potential of the mRNA pipeline. Barchart · Sep 8, 2023
FDA approves updated Moderna and Pfizer Covid boosters set to arrive soon as cases rise: Latest An updated Coronavirus booster that targets a new variant is expected to be made available in September The Independent UK · Sep 8, 2023
Jets' Aaron Rodgers shows support for unvaccinated tennis star Novak Djokovic Aaron Rodgers crossed an item off his sports bucket list and then made a statement with a more visible crossout The Independent UK · Sep 7, 2023
New Covid variant ‘Pirola’ sparks case rise across US and Canada as Moderna shares vaccine update – latest An updated Coronavirus booster that targets a new variant is expected to be made available in September The Independent UK · Sep 7, 2023
Former Covid medical officer Van-Tam takes role at vaccine maker Moderna One of UK’s public faces of pandemic, ‘JVT’ was known for football-related metaphors in No 10 briefings The Guardian - UK · Aug 18, 2023
Covid booster jabs could go on sale privately in UK in 2024 Health officials reiterate support for private provision as lower age limit for NHS booster vaccines raised to 65 The Guardian - UK · Aug 17, 2023
Ex-medical chief Jonathan Van-Tam takes job with Covid vaccine giant Moderna Move may spark fresh questions over ‘revolving door’ between government and business The Independent UK · Aug 17, 2023
When Should You Get Your Next Covid-19 Booster? There’s One Easy Answer To This Question Vaccine manufacturers like Pfizer/BioNTech, Moderna, and Novavax are switching up their shots in preparation for the new season. Inverse · Aug 17, 2023
Covid vaccines should be available to buy privately in UK, scientists say People not eligible for autumn booster programme should have option to pay for jab, experts argue, amid new wave concerns The Guardian - UK · Aug 17, 2023
Coronavirus FAQ: Is it wiser to get a booster now or wait for the new fall booster? Maybe it's not a full-blown summer surge but COVID numbers are ticking up. For those with concerns due to personal risk factors or the start of the school year, the booster question is top of mind. WEKU · Aug 11, 2023
For Flagship, Moderna’s COVID-19 vaccine is a tough act to follow Unorthodox, brash, and sometimes controversial, Flagship Pioneering is looking for its next blockbuster. Fortune · Aug 10, 2023
The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take Medical journals describe all-cause mortality in randomized controlled trials (RCTs) Zenger · Jul 30, 2023
Zenger · Jul 28, 2023 FDA Violated Own Safety And Efficacy Standards In Approving Covid-19 Vaccines For Children Evidence the FDA used for those decisions violates at least three safety and efficacy standards from earlier FDA publications
Fortune · Jul 25, 2023 Pfizer and Moderna parent are investing $100M to find the next big drug "What we are doing now, I don’t think anyone has done so far," Pfizer CEO Albert Bourla says.
Tribune News Service · Jul 6, 2023 Moderna signs deal to make mRNA vaccines for Chinese market Moderna Inc. will push toward producing messenger RNA vaccines for China, seeking a foothold in the world’s second-largest pharmaceutical market even as geopolitical tensions rise.
Inverse · Jul 5, 2023 A Long-Awaited Vaccine For Lyme Disease is Tantalizingly Close — Here's When It Could Be Available Over the past twenty years, Lyme disease cases have continued to climb, and we are finally tantalizingly close to another vaccine.
The Guardian - UK · Jul 4, 2023 UK regulator sued for not investigating Covid vaccine ‘misinformation’ Case brought against General Medical Council for failure to look into claimed links to heart problems and deaths
Fortune · Jun 30, 2023 Health care providers are adding cloud tech, but need to dream bigger Currently, the application of cloud in the health care space is choppy.
Fortune · Jun 26, 2023 Cancer vaccines are already a reality. Here's what you need to know about the cutting-edge technology that could usher in an era of personalized medicine The concept may seem torn from the plot of some futuristic sci-fi movie, or from the pages of some decades-old utopian novel far ahead of its time. But such wonders of science exist today.
Zenger · Jun 26, 2023 Moderna Stock Rises After FDA Application For Updated Vaccine Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy
StockNews.com · Jun 21, 2023 Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In? Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.
Inverse · Jun 18, 2023 mRNA Vaccines Could Revolutionize Cancer Treatment Here’s a look at the status of mRNA technology's application in cancer and when it might reach patients.
Wales Online · Jun 11, 2023 Devastating virus few parents know about hits three babies a day World-first vaccine trials have now begun in a bid to protect children from CMV